» Articles » PMID: 17948050

Malt1 Ubiquitination Triggers NF-kappaB Signaling Upon T-cell Activation

Overview
Journal EMBO J
Date 2007 Oct 20
PMID 17948050
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Triggering of antigen receptors on lymphocytes is critical for initiating adaptive immune response against pathogens. T-cell receptor (TCR) engagement induces the formation of the Carma1-Bcl10-Malt1 (CBM) complex that is essential for activation of the IkappaB kinase (IKK)/NF-kappaB pathway. However, the molecular mechanisms that link CBM complex formation to IKK activation remain unclear. Here we report that Malt1 is polyubiquitinated upon T-cell activation. Ubiquitin chains on Malt1 provide a docking surface for the recruitment of the IKK regulatory subunit NEMO/IKKgamma. TRAF6 associates with Malt1 in response to T-cell activation and can function as an E3 ligase for Malt1 in vitro and in vivo, mediating lysine 63-linked ubiquitination of Malt1. Multiple lysine residues in the C-terminus of Malt1 serve as acceptor sites for the assembly of polyubiquitin chains. Malt1 mutants that lack C-terminal ubiquitin acceptor lysines are impaired in rescuing NF-kappaB signaling and IL-2 production in Malt1-/- T cells. Thus, our data demonstrate that induced Malt1 ubiquitination is critical for the engagement of CBM and IKK complexes, thereby directing TCR signals to the canonical NF-kappaB pathway.

Citing Articles

NEMO Family of Proteins as Polyubiquitin Receptors: Illustrating Non-Degradative Polyubiquitination's Roles in Health and Disease.

Wu C Cells. 2025; 14(4).

PMID: 39996775 PMC: 11854354. DOI: 10.3390/cells14040304.


Ubiquitination of Immune System and Cancer Therapy.

Du Y, Zhang H, Hu H Adv Exp Med Biol. 2024; 1466:35-45.

PMID: 39546134 DOI: 10.1007/978-981-97-7288-9_3.


The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway.

Wang Y, Deng X, Xie J, Lu T, Qian R, Guo Z Cell Biol Toxicol. 2024; 40(1):45.

PMID: 38864940 PMC: 11169058. DOI: 10.1007/s10565-024-09888-z.


Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death.

Yao Y, Yuan M, Shi M, Li W, Sha Y, Zhang Y Blood Adv. 2024; 8(15):4003-4016.

PMID: 38820414 PMC: 11339052. DOI: 10.1182/bloodadvances.2023012394.


TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functions.

ONeill T, Gewies A, Seeholzer T, Krappmann D Front Immunol. 2023; 14:1111398.

PMID: 36761777 PMC: 9902345. DOI: 10.3389/fimmu.2023.1111398.


References
1.
Schulze-Luehrmann J, Ghosh S . Antigen-receptor signaling to nuclear factor kappa B. Immunity. 2006; 25(5):701-15. DOI: 10.1016/j.immuni.2006.10.010. View

2.
Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H . A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene. 1999; 18(42):5785-94. DOI: 10.1038/sj.onc.1203018. View

3.
Wan Y, Chi H, Xie M, Schneider M, Flavell R . The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol. 2006; 7(8):851-8. DOI: 10.1038/ni1355. View

4.
Shambharkar P, Blonska M, Pappu B, Li H, You Y, Sakurai H . Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways. EMBO J. 2007; 26(7):1794-805. PMC: 1847656. DOI: 10.1038/sj.emboj.7601622. View

5.
Ruland J, Duncan G, Wakeham A, Mak T . Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity. 2003; 19(5):749-58. DOI: 10.1016/s1074-7613(03)00293-0. View